Tolerability and efficacy of chemotherapy in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Seruga, B
  • Horgan, AM
  • Pond, Gregory
  • Alibhai, SMH
  • Amir, E
  • De Wit, R
  • Eisenberger, MA
  • Tannock, I

publication date

  • May 20, 2011